PHARMA 4.0

Sales & Marketing

With healthcare marketing becoming more digital than ever, artificial intelligence (AI) for marketers has ceased to be merely a buzzword.

Partner Content

Partner Content

Parallel Trade Conference

News

Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.